In conclusion, these data suggested that the repression of classical AhR signaling, a phenotype driven by exposure to BMAs, is predictive of worse clinical outcomes in MM patients, supporting the evidence that MM patients with obesity have increased risk for disease progression. Here, AHR is linked to Obesity.